Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Hillas

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
ERJ Open Research|June 18, 2024
Mortality prevention as the centre of COPD managementAndriana I Papaioannou, Georgios Hillas, Stelios Loukides, et al.
Journal of Personalized Medicine|May 28, 2022
Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered QuestionsEvangelia Fouka, Andriana I Papaioannou, Georgios Hillas, et al.
ERJ Open Research|September 9, 2020
Primary care and COVID-19: cutting the Gordian knot - the Greek experience and algorithmIoannis Tomos, Konstantinos Kostikas, Georgios Hillas, et al.
Expert Opinion on Investigational Drugs|January 16, 2018
Targeted anti-IL-13 therapies in asthma: current data and future perspectivesPolyxeni Ntontsi, Evgenia Papathanassiou, Stelios Loukides, et al.
Expert Opinion on Investigational Drugs|January 26, 2019
Experimental and investigational phosphodiesterase inhibitors in development for asthmaPolyxeni Ntontsi, Aggeliki Detta, Petros Bakakos, et al.
Expert Review of Respiratory Medicine|October 7, 2025
COPD and the burden of multimorbidity: navigating the complexityMaria Kallieri, Georgios Hillas, Konstantinos Bartziokas, et al.
Journal of Clinical Medicine|March 14, 2026
Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic DrugsMaria Kallieri, Georgios Hillas, Stelios Loukides, et al.
International Journal of Molecular Sciences|May 4, 2026
The Role of Cellular Senescence in Obstructive Airway Diseases: From Mechanisms to Therapeutic TargetsArgyro Vrouvaki, Marina Moustaka Christodoulou, Georgios Hillas, et al.
Expert Review of Respiratory Medicine|November 25, 2021
Blood eosinophils in COPD: friend or foe?Anastasia Papaporfyriou, Petros Bakakos, Georgios Hillas, et al.
Postgraduate Medicine|October 13, 2022
Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needsKostantinos Bartziokas, Anastasia Papaporfyriou, Georgios Hillas, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
ERJ Open Research|June 18, 2024
Mortality prevention as the centre of COPD managementAndriana I Papaioannou, Georgios Hillas, Stelios Loukides, et al.
Journal of Personalized Medicine|May 28, 2022
Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered QuestionsEvangelia Fouka, Andriana I Papaioannou, Georgios Hillas, et al.
ERJ Open Research|September 9, 2020
Primary care and COVID-19: cutting the Gordian knot - the Greek experience and algorithmIoannis Tomos, Konstantinos Kostikas, Georgios Hillas, et al.
Expert Opinion on Investigational Drugs|January 16, 2018
Targeted anti-IL-13 therapies in asthma: current data and future perspectivesPolyxeni Ntontsi, Evgenia Papathanassiou, Stelios Loukides, et al.
Expert Opinion on Investigational Drugs|January 26, 2019
Experimental and investigational phosphodiesterase inhibitors in development for asthmaPolyxeni Ntontsi, Aggeliki Detta, Petros Bakakos, et al.
Expert Review of Respiratory Medicine|October 7, 2025
COPD and the burden of multimorbidity: navigating the complexityMaria Kallieri, Georgios Hillas, Konstantinos Bartziokas, et al.
Journal of Clinical Medicine|March 14, 2026
Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic DrugsMaria Kallieri, Georgios Hillas, Stelios Loukides, et al.
International Journal of Molecular Sciences|May 4, 2026
The Role of Cellular Senescence in Obstructive Airway Diseases: From Mechanisms to Therapeutic TargetsArgyro Vrouvaki, Marina Moustaka Christodoulou, Georgios Hillas, et al.
Expert Review of Respiratory Medicine|November 25, 2021
Blood eosinophils in COPD: friend or foe?Anastasia Papaporfyriou, Petros Bakakos, Georgios Hillas, et al.
Postgraduate Medicine|October 13, 2022
Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needsKostantinos Bartziokas, Anastasia Papaporfyriou, Georgios Hillas, et al.
Pageof 8